Source: Annual Congress 2006 - In vivo and in vitro aspects of lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. S. Pullamsetti, R. Dumistrasu, R. Savai, B. K. Dahal, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, A. Guenther, R. T. Schermuly (Giessen, Germany). Increased alveolar epithelial expression of dimethylarginine dimethylaminohydrolase 2 in idiopathic pulmonary fibrosis. Eur Respir J 2006; 28: Suppl. 50, 4744

Member's Comments

No comment yet.

Related content which might interest you: Attenuated expression and activity of dimethylarginine dimethylaminohydrolase may play a key role in monocrotaline-induced pulmonary hypertension by accumulation of endogenous NOS inhibitors in rats Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Hypoxia induced pulmonary hypertension – the role of dimethylarginine dimethylaminohydrolase 1 (DDAH-1) in acute and sustained hypoxic vasoconstriction Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Asymmetric dimethylarginine (ADMA) to monitor treatments of pulmonary hypertension Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Plasma asymmetric dimethylarginine (ADMA) in pediatric patients with cystic fibrosis (CF) Source: International Congress 2016 – Systemic biomarkers Year: 2016 Cyclo-oxygenase (Cox)-2 is not upregulated in idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 410s Year: 2001 Role of the nitric oxide-asymmetric dimethylarginine-dimethylarginine dimethylaminohydrolase (NO-ADMA-DDAH) axis in TGF-β mediated epithelial-mesenchymal transition Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009 The role of asymmetric dimethylarginine (ADMA) in patients with asthma Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Prognostic evaluation of alveolar concentration of nitric oxide, serum periostin and CD59 in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 High expression of telomerase/endothelin-1 increase replication and activation of vascular myofibroblasts in usual interstitial pneumonia/idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021